Edap Tms SA (FOCL) FinancialsFOCLEdap Tms SA

Edap Tms SA (FOCL) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is High Intensity Focused Ultrasound Division, accounting for 65.1% of total sales, equivalent to $11.59M. Other significant revenue streams include Distribution Division and ESWL Division. Understanding this composition is critical for investors evaluating how FOCL navigates market cycles within the Advanced Medical Equipment & Technology industry.

Evaluating the bottom line, Edap Tms SA maintains a gross margin of 55.58%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -60.84%, while the net margin is -109.16%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively FOCL converts its operational activities into shareholder value.

In the context of the broader market, FOCL competes directly with industry leaders such as KRMD and NYXH. With a market capitalization of $178.63M, it holds a leading position in the sector. When comparing efficiency, FOCL's gross margin of 55.58% stands against KRMD's 63.39% and NYXH's 59.73%. Such benchmarking helps identify whether Edap Tms SA is trading at a premium or discount relative to its financial performance.

The company's revenue for Q2 2026 was reported at $13.2 million, a 39% increase year-over-year, but it continues to post negative net income, with Q2 2026 losses at -14,487,000 USD.